Sponsor Pipeline

Tubulis GmbH Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
8
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-12 NCT07736937
Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing…		 Trial sites expanded: 5 -> 8 locations
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-04 NCT07743541 Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After… Phase 1/2 Not Yet Recruiting
2026-07-30 NCT07736937 Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing… Phase 1/2 Recruiting
Active Trials by Phase
Phase 1/2
4
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06303505 FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients… Ovarian Cancer Recruiting
NCT07736937 Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing… Ovarian Cancer Recruiting
NCT06657222 First in Human Study of TUB-030 in Patients With Advanced Solid Tumors Advanced Solid Tumors Recruiting
NCT07743541 Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After… Uterine Endometrial Cancer Not Yet Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Ovarian Cancer (2) Lung Cancer (1) Small Cell Lung Cancer (1) Breast Cancer (1) Triple-Negative Breast Cancer (1) Head & Neck Cancer (1) Endometrial Cancer (1)
Get alerts when Tubulis GmbH's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free